Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

2024
type: Class

Generically Dependent Continuant
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-31T17:44:42
publisher: 2 A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
label: RDF description of 2 A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes - http://research.umh.es/vivo/pub/articulo/279024

2 A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
type: 2024
related by: Autor:35232-Artículo:279024
included: Medicina Clínica 2024
type: Article
ARG_2000028: 279024 vcard
type: Thing
most specific type: Academic Article
type: Document
type: Information Content Entity
most specific type: 2024
date time value: 279024 pubdate
type: Academic Article
has publication venue: OPEN FORUM INFECTIOUS DISEASES
type: Generically Dependent Continuant
type: Anualidad
type: Entity
related by: Autor:36736-Artículo:279024
type: Continuant

Autor:35232-Artículo:279024
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: 2 A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes

Medicina Clínica 2024
type: Anualidad
type: 2024
type: DepartmentReport
type: Thing
type: ResearchReport
includes: 2 A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes

OPEN FORUM INFECTIOUS DISEASES
type: Journal
type: Collection
publication venue for: 2 A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
type: Thing
type: Continuant
type: Periodical
type: Entity
type: Generically Dependent Continuant
type: Information Content Entity

Autor:36736-Artículo:279024
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: 2 A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes